- Filed
- Mar 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 28, 2025 | 34.05M sh |
| Long Term Debt | Q3 2025 · Jan 25, 2025 | $141.2M |
| Long Term Debt | Q3 2025 · Apr 27, 2024 | $196.34M |
| Long Term Debt | Q3 2025 · Jan 27, 2024 | $30.19M |
| Short Term Debt | Q3 2025 · Jan 25, 2025 | $0 |
| Short Term Debt | Q3 2025 · Apr 27, 2024 | $0 |
| Short Term Debt | Q3 2025 · Jan 27, 2024 | $224.07M |
| Cash And Equivalents | Q3 2025 · Jan 25, 2025 | $9.19M |
| Cash And Equivalents | Q3 2025 · Apr 27, 2024 | $10.46M |
| Cash And Equivalents | Q3 2025 · Jan 27, 2024 | $8.12M |
| Current Liabilities | Q3 2025 · Jan 25, 2025 | $534.71M |
| Current Liabilities | Q3 2025 · Apr 27, 2024 | $478.8M |
| Current Liabilities | Q3 2025 · Jan 27, 2024 | $849.59M |
| Total Liabilities | Q3 2025 · Jan 25, 2025 | $804.26M |
| Total Liabilities | Q3 2025 · Apr 27, 2024 | $834.51M |
| Total Liabilities | Q3 2025 · Jan 27, 2024 | $1.05B |
| Current Assets | Q3 2025 · Jan 25, 2025 | $758.01M |
| Current Assets | Q3 2025 · Apr 27, 2024 | $530.76M |
| Current Assets | Q3 2025 · Jan 27, 2024 | $763.65M |
| Total Assets | Q3 2025 · Jan 25, 2025 | $1.09B |
| Total Assets | Q3 2025 · Apr 27, 2024 | $905.08M |
| Total Assets | Q3 2025 · Jan 27, 2024 | $1.15B |
| Shares Diluted restated | Q3 2025 · Jan 27, 2024 | 2.67M sh |
| Shares Diluted restated | Q3 2025 · Jan 27, 2024 | 2.66M sh |
| Stock Repurchased | Q3 2025 · Jan 27, 2024 | $176K |
| Capex | Q3 2025 · Jan 27, 2024 | $11.46M |
| Operating Cash Flow | Q3 2025 · Jan 27, 2024 | −$86.87M |
| Stockholders Equity | Q3 2025 · Jan 27, 2024 | $97.13M |
| Stockholders Equity | Q3 2025 · Oct 28, 2023 | $105.96M |
| Stockholders Equity | Q3 2025 · Jul 29, 2023 | $81.06M |
| Stockholders Equity | Q3 2025 · Apr 29, 2023 | $130.75M |
| Eps Diluted restated | Q3 2025 · Jan 27, 2024 | −$3.60 |
| Eps Diluted restated | Q3 2025 · Jan 27, 2024 | −$13.48 |
| Eps Basic restated | Q3 2025 · Jan 27, 2024 | −$3.60 |
| Eps Basic restated | Q3 2025 · Jan 27, 2024 | −$13.48 |
| Sga Expense | Q3 2025 · Jan 27, 2024 | $79.76M |
| Sga Expense | Q3 2025 · Jan 27, 2024 | $243.19M |
| Net Income | Q3 2025 · Jan 27, 2024 | −$9.64M |
| Net Income | Q3 2025 · Jan 27, 2024 | −$35.85M |
| Net Income | Q3 2025 · Oct 28, 2023 | $24.18M |
| Net Income | Q3 2025 · Jul 29, 2023 | −$50.39M |
| Operating Income | Q3 2025 · Jan 27, 2024 | $921K |
| Operating Income | Q3 2025 · Jan 27, 2024 | −$4.98M |
| Gross Profit | Q3 2025 · Jan 27, 2024 | $100.04M |
| Gross Profit | Q3 2025 · Jan 27, 2024 | $286.91M |
| Cost Of Revenue | Q3 2025 · Jan 27, 2024 | $356.64M |
| Cost Of Revenue | Q3 2025 · Jan 27, 2024 | $1.04B |